In one of the interviews (I think it was Proactive), Dr T estimated that it would cost about 500M to conduct all those 40 x historical trials.
RAC inherits all that historical data for free.
And the MC is only 320M - undervalued.
Add to that the success of the AML clinical trial, pre-clinal breast cancer results, and City of Hope linking bisantrene to FTO, and you begin to see RAC being undervaled even further.
Heaps of upside to go...
In one of the interviews (I think it was Proactive), Dr T...
-
- There are more pages in this discussion • 18,108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
-0.010(0.55%) |
Mkt cap ! $307.3M | |||
| Open | High | Low | Value | Volume |
| $1.83 | $1.84 | $1.78 | $271.2K | 150.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 349 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |